Stock listing

A2JPMY Stock Price, News, Filings & Events — Neuronetics, Inc.

Selected listing: A2JPMY · LSX · EUR · DE

A2JPMY:LSX is the public stock listing for Neuronetics, Inc., a company focused on developing and commercializing innovative non-invasive therapies for psychiatric and neurological disorders. Recently, Neuronetics has been involved in expanding its product offerings and enhancing its market presence through strategic initiatives. Investors can find the latest news, regulatory filings, and upcoming events related to the company on this page, providing insights into its operational developments and market performance. The context of the mental health treatment landscape continues to evolve, influencing Neuronetics' growth potential and strategic direction.

A2JPMY:LSXEURDEUpdated July 21, 2026
Neuronetics, Inc. logo
Ticker
A2JPMY:LSX
Asset type
Stock
Market cap
$112.7M
Sector
Health Technology
Industry
Medical Specialties
Exchange
LSX
Currency
EUR

Neuronetics, Inc. A2JPMY:LSX stock context

A2JPMY:LSX is the public stock listing for Neuronetics, Inc., a company focused on developing and commercializing innovative non-invasive therapies for psychiatric and neurological disorders. Recently, Neuronetics has been involved in expanding its product offerings and enhancing its market presence through strategic initiatives. Investors can find the latest news, regulatory filings, and upcoming events related to the company on this page, providing insights into its operational developments and market performance. The context of the mental health treatment landscape continues to evolve, influencing Neuronetics' growth potential and strategic direction.

Research Neuronetics, Inc.

Alternate listings